市場調查報告書
商品編碼
1055836

全球泌尿疾病治療市場:COVID-19 的增長、趨勢、影響、預測(2022-2027 年)

Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球泌尿道疾病治療市場預計在預測期內以 4.2% 的複合年增長率增長。

腎結石和泌尿系統疾病的增加、癌症發病率的增加以及導管和支架的技術進步是市場的主要驅動力。

本報告調查了全球泌尿道疾病治療市場,概述了市場、治療趨勢、最終用戶和地區,以及進入市場的公司概況。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第四章市場動態

  • 市場概況
  • 市場促進因素
    • 泌尿系統疾病患病率增加
    • 導管和支架所用原材料的技術進步
  • 市場製約因素
    • 支架和導管感染風險
    • 支架和導管引起的不適和疼痛
  • 波特五力分析

第 5 章市場細分

  • 按治療
    • 設備
    • 藥物
  • 最終用戶
    • 醫院/診所
    • 門診手術中心
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭態勢

  • 公司簡介
    • Boston Scientific Corporation
    • Cook Medical
    • Bayer AG
    • Sanofi
    • B. Braun Melsungen AG
    • C. R. Bard, Inc
    • Olympus Corporation
    • Teleflex Incorporated
    • Merit Medical Systems, Inc
    • Argon Medical Devices, Inc

第7章 市場機會與未來動向

目錄
Product Code: 68896

The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period. Uropathy/obstructive uropathy may occur due to kidney stones, bladder stones, blood clots, uterine cancer, colon cancer, cervical cancer, and problems with the nerves that supply the bladder. Treatment available for management of uropathy includes stents, catheters and drugs.

According to a study published in Advances in Urology, Kidney stone disease is an increasing urological disorder of human health which is affecting about 15% of the world population and it affects all age groups but occurs more frequently in men than in women within the age of 20-49 years. Moreover, during lifetime, approximately 7% of women and 13% of men will develop a kidney stone.

Increasing prevalence of kidney stone, urological disorders and rising incidence of cancer and technological advancement in catheters and stents are the key driving factors in uropathy treatment market.

Key Market Trends

Stents Segment is Expected to Hold a Major Market Share in the Uropathy Treatment Market

  • A stent is a thin tube used to prevent or treat a blockage that prevents the flow of urine from the kidneys. The length of the stents used in adult patients varies between 24 and 30 cm. Additionally, stents come in differing gauges or diameters, to fit different size ureters.
  • According to the American Academy of Family Physicians (AAFP), Kidney stones are a common disorder, with an annual incidence of eight cases per 1,000 adults. Moreover, around 13% of men and 7% of women develop a kidney stone in their lifetime and the overall incidence of urinary retention is 4.5 to 6.8 per 1,000 men, per year, in the United States. Moreover, the stent is used when there is a blockage in the ureter (in case of kidney stones) and allows urine to drain around the blockage and also decrease the pain associated with the blockage (i.e. kidney stone). In some cases, infection associated with the kidney stone stents helps to drain the infected urine.
  • Stents segment holds a significant market share in the uropathy treatment market and is anticipated to show a similar trend over the forecast period due to the availability of specific product types according to the requirements.
  • Increasing prevalence of urological disorders and technological advancement in the material used for stents are the key driving factors in the stents segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global uropathy treatment market due to increasing prevalence of kidney stones in this region. According to a study published in the Clinical Journal of the American Society of Nephrology, in the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. In addition, the frequency of urinary stone disease (USD) in children is increasing (4%-6%) yearly, particularly among adolescents. Furthermore, the increase in technological advancements and new product launches, and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Uropathy Treatment Market is fragmented competitive and consists of several major players. Some of the leading companies operating in the market include Boston Scientific Corporation, Cook Medical, Bayer AG, Sanofi, B. Braun Melsungen AG, C. R. Bard, Inc, Olympus Corporation, Teleflex Incorporated, Merit Medical Systems, Inc and Argon Medical Devices, Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Urological Disorders
    • 4.2.2 Technological Advancement in the Material Used for Catheters and Stents
  • 4.3 Market Restraints
    • 4.3.1 Risk of Infection due to Stents and Catheters
    • 4.3.2 Discomfort and Pain due to Stents and Catheters
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Treatment
    • 5.1.1 Devices
      • 5.1.1.1 Catheters
      • 5.1.1.2 Stents
      • 5.1.1.3 Other Devices
    • 5.1.2 Drugs
  • 5.2 End-user
    • 5.2.1 Hospitals and Clinics
    • 5.2.2 Ambulatory Surgical Centre
    • 5.2.3 Other End-users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Cook Medical
    • 6.1.3 Bayer AG
    • 6.1.4 Sanofi
    • 6.1.5 B. Braun Melsungen AG
    • 6.1.6 C. R. Bard, Inc
    • 6.1.7 Olympus Corporation
    • 6.1.8 Teleflex Incorporated
    • 6.1.9 Merit Medical Systems, Inc
    • 6.1.10 Argon Medical Devices, Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS